KKR & Co. Inc. (KKR)
| Market Cap | 122.20B |
| Revenue (ttm) | 20.31B |
| Net Income (ttm) | 2.19B |
| Shares Out | 890.64M |
| EPS (ttm) | 2.37 |
| PE Ratio | 57.99 |
| Forward PE | 25.60 |
| Dividend | $0.74 (0.54%) |
| Ex-Dividend Date | May 12, 2025 |
| Volume | 2,671,613 |
| Open | 139.43 |
| Previous Close | 139.43 |
| Day's Range | 136.74 - 140.27 |
| 52-Week Range | 86.15 - 170.40 |
| Beta | 1.88 |
| Analysts | Strong Buy |
| Price Target | 151.41 (+10.35%) |
| Earnings Date | Jul 31, 2025 |
About KKR
KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, fintech, data and information, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, informatio... [Read more]
Financial Performance
In 2024, KKR & Co.'s revenue was $26.42 billion, an increase of 41.57% compared to the previous year's $18.66 billion. Earnings were $3.08 billion, a decrease of -16.42%.
Financial StatementsAnalyst Summary
According to 17 analysts, the average rating for KKR stock is "Strong Buy." The 12-month stock price target is $151.41, which is an increase of 10.35% from the latest price.
News
KKR & Co. Inc. to Announce Second Quarter 2025 Results
NEW YORK--(BUSINESS WIRE)--KKR & Co. Inc. (NYSE: KKR) announced today that it plans to release its financial results for the second quarter 2025 on Thursday, July 31, 2025, before the opening of tradi...
Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million
Transaction Advances Company's 'Three-S' Plan to Streamline its Portfolio and Strengthen Focus on its 'High-Grow' Brands Total Consideration of Up to €327 Million, Consisting of €300 Million in Upfron...
FSK Announces Earnings Release and Conference Call Schedule for Second Quarter 2025
PHILADELPHIA and NEW YORK , July 10, 2025 /PRNewswire/ -- FS KKR Capital Corp. (NYSE: FSK) announced today plans to release its second quarter 2025 results after the close of trading on the New York S...
Analysts Think Alt Manager KKR Is a Buy Again
KKR stock trades at about 20 times the consensus estimate for around $6.65 a share in earnings next year.
KKR & Co: Entry Opportunity Into A Long-Term Compounder
Fee-related earnings and AUM continue to grow steadily. The insurance business caused short-term volatility but has long-term potential. Market risks and low realizations remain, but the business mode...
Retire With Long-Term Investment Grade Bonds (Part 5): KKR & Co. Inc.
KKR & Co. Inc. boasts strong fundamentals, outperforming SPY and peers, with a robust asset base and investment-grade credit ratings. The company has a 14-year streak of uninterrupted dividends, with ...
KKR agrees to buy Spectris in $6.5 billion deal, tops Advent offer
Britain's Spectris has accepted an improved takeover offer from U.S. private equity firm KKR , valuing the scientific instruments maker at about 4.7 billion pounds ($6.46 billion), including debt, the...
KKR to acquire Australian chicken grower ProTen from Aware Super
Private equity group KKR will acquire ProTen, one of Australia's largest broiler chicken growers, from pension fund Aware Super, the parties said in a joint statement on Wednesday without disclosing f...
KKR Acquires ProTen from Aware Super
SYDNEY--(BUSINESS WIRE)--KKR Acquires ProTen from Aware Super.
KKR Makes Second Residential Investment in Stockholm with Three Asset Multifamily Development in Täby
STOCKHOLM--(BUSINESS WIRE)--KKR, a leading global investment firm, today announced the agreement with leading Swedish developer Reliwe for the forward funding of a new multifamily development in Täby,...
KKR Launches Financial Advisory Platform Ascend Asia in Singapore
SINGAPORE--(BUSINESS WIRE)--KKR Launches Financial Advisory Platform Ascend Asia in Singapore.
My 2 Newest REIT Investments
We have sold many investments in recent months. We have then reinvested the proceeds in new opportunities. Here are 2 of our newest investments.
Torrent Pharma to Acquire Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKR
MUMBAI, India--(BUSINESS WIRE)--Torrent Pharma to Acquire Controlling Stake in J. B. Chemicals & Pharmaceuticals from KKR.
Final Trades: KKR & Co, Lululemon, Meta and Rockwell Automation
The Investment Committee give you their top stocks to watch for the second half.
Final Trades: Rocket Companies, KKR, GXO Logistics and Uber
The Investment Committee give you their top stocks to watch for the second half.
KKR Announces Intra-Quarter Monetization Activity Update for the Second Quarter
NEW YORK--(BUSINESS WIRE)--KKR today announced a monetization activity update for the period from April 1, 2025 to June 20, 2025. Based on information available to us as of today, with respect to the ...
KKR to Acquire Australian Power Provider Zenith Energy
The investment firm said it is buying Zenith from a consortium including Pacific Equity Partners, OPSEU Pension Trust and Foresight Group.
KKR to buy Australia's Zenith Energy from consortium
Private equity firm KKR said on Tuesday it had agreed to acquire Australian power producer Zenith Energy from a consortium comprising Australia-based Pacific Equity Partners, Canada's OPSEU Pension Tr...
KKR Acquires Leading Australian Independent Power Producer Zenith Energy
SYDNEY--(BUSINESS WIRE)--KKR Acquires Leading Australian Independent Power Producer Zenith Energy.
Important Warning For Infrastructure Stocks: 4 Major Looming Risks
Infrastructure investing offers durable cash flows and strong dividend growth potential, making it attractive amid rising institutional interest and AI-driven capital spending. However, there are majo...
UK's Spectris rejects second KKR takeover approach in favour of Advent's $5 billion proposal
Britain's Spectris said on Friday it has rejected a second takeover proposal from private equity firm KKR, days after the scientific instruments maker backed a possible competing $5 billion bid from A...
KKR Making Competing Bid for Equipment Maker Spectris
The private-equity firm plans to bid against rival Advent International, which submitted a roughly $5 billion proposal.
UK's PHP urges Assura to back its bid over KKR-Stonepeak offer
British healthcare real estate investor Primary Health Properties (PHP) on Friday urged rival Assura to back its bid over a takeover offer from KKR and Stonepeak.
Auto Supplier Marelli Files for Bankruptcy to Hand Lenders Control
KKR's Marelli blames tariffs and lingering supply-chain issues stemming from the Covid-19 pandemic for its descent into chapter 11.